!

COVID-19 Response

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

About Us

Record of Success

Master
Content

Past success is an excellent of predictor of future success in commercialization. Our achievements demonstrate that BLG has the skills, knowledge and experience to help you.

Read highlights below for a selection of featured license agreements and licensing relationships with established industry partners, investor groups, and startup companies, as well as collaboration with our peer academic institutions to commercialize jointly-developed inventions.

Heading

Developments with Longstanding Licensing Relationships

Terms

Takeda Pharmaceuticals

Item Definition

A Decade of Academia-Industry Joint Efforts in Developing a Human Norovirus Vaccine Candidate.

Opexa Therapeutics, Inc.

Item Definition

Opexa Therapeutics Reaches Clinical Development Milestone Event in Development of a Personalized Therapy for Secondary Progressive Multiple Sclerosis.

TyRx, Inc.

Item Definition

TyRx, Inc., Expands Market and Introduces Bioresorbable AIGISRx R Antibacterial Envelope.

Heading

Exclusive License Agreements

Terms

Celgene Corporation

Item Definition

Celgene, bluebird bio, and the Center for Cell and Gene Therapy Combine Strengths and Resources to Develop T-cell Based Therapies for Cancer

Vax-Immune, LLC

Item Definition

Vax-Immune Acquires Exclusive Worldwide Rights to Baylor College of Medicine’s Ureaplasma Technology.

Shenzhen Tiande Investment Co., LTD.

Item Definition

Shenzhen Tiande Investment Co., LTD., Licenses Esophageal Cancer Biomarkers.

Acer Therapeutics, Inc.

Item Definition

Acer Therapeutics Develops the First Pharmaceutical Therapy for Maple Syrup Urine Disease (MSUD)

StemMed, Ltd.

Item Definition

StemMed, Ltd., Licenses STAT3 Inhibitors - Local Company Developing Novel Compounds Against a Key Cancer Target

Heading

Non-Exclusive Licensed Technologies

Terms

pINDUCER Lentiviral Vectors

Item Definition

pINDUCER Lentiviral Vectors for Inducible RNAi in vitro and in vivo.

The TRAMP Mouse Model and Cell Lines

Item Definition

The TRAMP Mouse Model and Cell Lines - A Research Tool’s Popularity Marches On

Heading

Master Agreements

Terms

American Type Culture Collection (ATCC)

Item Definition

ATCC Master Agreement - BCM Poised to Benefit from Commercial Use of Deposited Materials.

Heading

The Estes lab and ImmuCell Success Story

Content

After more than 20 years of research, discoveries from the lab of Dr. Mary Estes reached the point where they evolved into practical applications that improve the quality of life.

Heading

BLG Annual Report 2016

Content

View the FY'16 annual report pdf for information on the year in review, agreement highlights, profiles in innovation, and more.